142 related articles for article (PubMed ID: 2933176)
1. In vitro responsiveness of ovarian epithelial carcinomas to endocrine therapy.
Runge HM; Teufel G; Neulen J; Geyer H; Pfleiderer A
Cancer Chemother Pharmacol; 1986; 16(1):58-63. PubMed ID: 2933176
[TBL] [Abstract][Full Text] [Related]
2. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
3. Growth patterns and hormonal sensitivity of primary tumor, abdominal metastasis and ascitic fluid from human epithelial ovarian carcinomas in the tumor colony-forming assay.
Runge HM; Neumann HA; Bauknecht T; Pfleiderer A
Eur J Cancer Clin Oncol; 1986 Jun; 22(6):691-6. PubMed ID: 3743604
[TBL] [Abstract][Full Text] [Related]
4. [Hormone dependence of malignant ovarian tumors--an in vitro model].
Schieder K; Bieglmayer C; Kölbl H
Geburtshilfe Frauenheilkd; 1989 May; 49(5):437-41. PubMed ID: 2544477
[TBL] [Abstract][Full Text] [Related]
5. [Significance of the colony formation test in ovarian carcinoma].
Runge HM; Bücke W; Neumann HA
Onkologie; 1984 May; 7 Suppl 2():66-73. PubMed ID: 6235468
[TBL] [Abstract][Full Text] [Related]
6. The importance of gestagen, tamoxifen and steroid receptors in the therapy of endometrial cancer. Report of an experiment.
Kleine W; Fuchs A; Pfleiderer A
Acta Obstet Gynecol Scand; 1982; 61(5):449-53. PubMed ID: 7158310
[TBL] [Abstract][Full Text] [Related]
7. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
[TBL] [Abstract][Full Text] [Related]
8. Estrogen activates migration potential of endometrial cancer cells through basement membrane.
Fujimoto J; Hori M; Ichigo S; Morishita S; Tamaya T
Tumour Biol; 1996; 17(1):48-57. PubMed ID: 7501972
[TBL] [Abstract][Full Text] [Related]
9. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
10. The growth response of BG-1 ovarian carcinoma cells to estradiol, 4OH-tamoxifen, and tamoxifen: evidence for intrinsic antiestrogen activation.
Pavlik EJ; Nelson K; van Nagell JR; Gallion HS; Donaldson ES; DePriest P; Meares K; van Nagell JR
Gynecol Oncol; 1991 Sep; 42(3):245-9. PubMed ID: 1955187
[TBL] [Abstract][Full Text] [Related]
11. Combined effects of estradiol, leuprorelin, tamoxifen and medroxyprogesterone acetate on cell growth and steroid hormone receptors in breast cancer cells.
Sica G; Iacopino F; Robustelli della Cuna G; Marchetti P; Marini L
J Cancer Res Clin Oncol; 1994; 120(10):605-9. PubMed ID: 7929532
[TBL] [Abstract][Full Text] [Related]
12. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells].
Nomura Y; Tashiro H; Takaeko F
Gan To Kagaku Ryoho; 1985 Apr; 12(4):844-50. PubMed ID: 3157351
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and anti-estrogen effects on the growth of human epithelial ovarian cancer in vitro.
Nash JD; Ozols RF; Smyth JF; Hamilton TC
Obstet Gynecol; 1989 Jun; 73(6):1009-16. PubMed ID: 2542854
[TBL] [Abstract][Full Text] [Related]
14. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
15. Steroid receptors and response of ovarian cancer to hormones in vitro.
Grönroos M; Kangas L; Mäenpää J; Vanharanta R; Nieminen AL; Johansson R
Br J Obstet Gynaecol; 1984 May; 91(5):472-8. PubMed ID: 6232944
[TBL] [Abstract][Full Text] [Related]
16. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
[TBL] [Abstract][Full Text] [Related]
17. Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay.
Osborne CK; Von Hoff DD; Mullins K
Breast Cancer Res Treat; 1985; 6(3):229-35. PubMed ID: 2936413
[TBL] [Abstract][Full Text] [Related]
18. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
Greenberger LM; Annable T; Collins KI; Komm BS; Lyttle CR; Miller CP; Satyaswaroop PG; Zhang Y; Frost P
Clin Cancer Res; 2001 Oct; 7(10):3166-77. PubMed ID: 11595711
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen and endometrial carcinoma: alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia.
Carlson JA; Allegra JC; Day TG; Wittliff JL
Am J Obstet Gynecol; 1984 May; 149(2):149-53. PubMed ID: 6232850
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibitory effect of LH-RH analogs on human breast cancer cells.
Scambia G; Panici PB; Baiocchi G; Perrone L; Gaggini C; Iacobelli S; Mancuso S
Anticancer Res; 1988; 8(1):187-90. PubMed ID: 2965864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
